LFVN Logo

LifeVantage Corporation (LFVN) 

NASDAQ
Market Cap
$174.48M
Sector
Consumer Defensive
Industry
Packaged Foods
Rank in Sector
38 of 142
Rank in Industry
17 of 41

Largest Insider Buys in Sector

LFVN Stock Price History Chart

LFVN Stock Performance

About LifeVantage Corporation

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to …

Insider Activity of LifeVantage Corporation

Over the last 12 months, insiders at LifeVantage Corporation have bought $68,056 and sold $33,000 worth of LifeVantage Corporation stock.

On average, over the past 5 years, insiders at LifeVantage Corporation have bought $119,887 and sold $512,671 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Mauro Garry Paul (director) — $54,568. Lewis Darwin (director) — $13,488.

The last purchase of 351 shares for transaction amount of $3,618 was made by Lewis Darwin (director) on 2024‑09‑17.

List of Insider Buy and Sell Transactions, LifeVantage Corporation

2024-09-17Purchasedirector
351
0.0029%
$10.31$3,618+20.35%
2024-09-03Purchasedirector
976
0.0075%
$7.41$7,227+53.57%
2024-06-14Purchasedirector
489
0.0037%
$7.38$3,610+27.68%
2024-03-15Purchasedirector
449
0.0035%
$7.00$3,142+5.86%
2024-02-02Purchasedirector
199
0.0016%
$5.67$1,128+25.22%
2023-12-15Purchasedirector
460
0.0037%
$6.78$3,118+5.02%
2023-11-20Saledirector
5,500
0.0444%
$6.00$33,000+17.29%
2023-11-16Purchasedirector
7,752
0.0591%
$4.75$36,801+42.41%
2023-11-15Purchasedirector
2,024
0.0156%
$4.65$9,411+44.20%
2023-09-22Purchasedirector
4,124
0.0325%
$6.94$28,632-2.16%
2023-09-05Purchasedirector
560
0.0044%
$7.63$4,274-10.32%
2023-08-25Purchase
5,490
0.0428%
$4.95$27,186+35.48%
2023-08-24Purchase
7,226
0.0577%
$4.82$34,837+37.42%
2023-08-23Purchase
3,788
0.0299%
$4.76$18,049+42.16%
2023-08-11Purchase
20,000
0.161%
$5.07$101,332+34.41%
2023-05-25Purchasedirector
2,000
0.0162%
$4.21$8,420+52.00%
2023-05-24Purchasedirector
3,000
0.0258%
$4.40$13,200+54.63%
2023-05-12Purchasedirector
150
0.0012%
$4.21$631+47.92%
2023-05-10Purchasedirector
3,820
0.0292%
$4.08$15,585+46.98%
2023-05-10Purchasedirector
170
0.0013%
$4.08$694+46.98%

Insider Historical Profitability

21.92%
Lewis Darwindirector
108342
0.865%
$13.9370+37.91%
Mauro Garry Pauldirector
77667
0.6201%
$13.93130+35.41%
BEINDORFF MICHAEL Adirector
54798
0.4375%
$13.93183+16.37%
Streets Daniel WTreasurer, Secretary, CFO
2048670
16.3564%
$13.9310<0.0001%
Thompson Jack R.director
919477
7.341%
$13.9340+282.13%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Renaissance Technologies$5.07M6.6837,818-0.04%-$1,815.070.01
The Vanguard Group$2.87M3.74475,021+2.77%+$77,494.45<0.0001
Dimensional Fund Advisors$1.87M2.44309,744-1.16%-$21,985.70<0.0001
Acadian Asset Management$1.38M1.8228,088+2.76%+$36,980.190.01
BlackRock$1.24M1.61204,697-0.39%-$4,894.45<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.